ALLOS THERAPEUTICS
Allos Therapeutics is a biopharmaceutical company that develops and commercializes anti-cancer therapeutics. FOLOTYN, the company’s main product is a folate analogue metabolic inhibitor design to accumulate preferentially in cancer cells so as to cause cell death. Allos Therapeutics was founded in 1992 and is headquartered in Westminster, Colorado. As of September 4, 2012, Allos Therapeutics operates as a subsidiary of Spectrum Pharmaceuticals, Inc.
ALLOS THERAPEUTICS
Industry:
Biotechnology Health Care
Founded:
1992-01-01
Address:
Westminster, Colorado, United States
Country:
United States
Total Employee:
101+
Status:
Active
Contact:
(303)426-6262
Total Funding:
0
Current Advisors List
Investors List
Aisling Capital
Aisling Capital investment in Private Equity Round - Allos Therapeutics
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2002-04-15 | N-Gene | Allos Therapeutics investment in Corporate Round - N-Gene | N/A |